Valuation: Pharmaniaga

Market Cap 1.56B 383M 335M 309M 284M 538M 36.82B 547M 3.68B 1.45B 18B 1.44B 1.41B 62.03B P/E 2026 *
20.7x
P/E 2027 * 17.6x
Enterprise Value 1.56B 383M 335M 309M 284M 538M 36.82B 547M 3.68B 1.45B 18B 1.44B 1.41B 62.03B EV / Sales 2026 *
0.38x
EV / Sales 2027 * 0.37x
Free-Float
37.97%
Yield 2026 *
9.03%
Yield 2027 * 12%
1 day-1.68%
1 week-4.88%
Current month+1.74%
1 month-0.85%
3 months-2.50%
6 months-20.68%
Current year-17.89%
1 week 1.17
Extreme 1.17
1.24
1 month 1.12
Extreme 1.12
1.3
Current year 1.12
Extreme 1.12
1.7
1 year 0.72
Extreme 0.725
1.7
3 years 0.65
Extreme 0.65
2.55
5 years 0.65
Extreme 0.65
4.72
10 years 0.65
Extreme 0.65
7.25
Manager TitleAgeSince
Chief Executive Officer 53 2024-08-31
Director of Finance/CFO 59 2012-05-31
Chief Administrative Officer 53 2024-09-30
Director TitleAgeSince
Director/Board Member 55 2020-11-19
Director/Board Member 53 2024-02-29
Director/Board Member 51 2021-08-19
Date Insider Type Main position Quantity % Market Cap.
03-26Buy

Director

300,000 0.0046%
Change 5-day change 1-year change 3-year change Capi.($)
-1.68%-4.88%+50.97%-39.22% 383M
-0.87%-2.73%+12.03%+94.47% 93.23B
-2.25%-5.15%+39.70%+141.51% 52.68B
+0.34%+2.44%+6.91%+284.31% 23.59B
+1.57%+4.39%-11.21%-20.01% 8.34B
+4.98%+8.64%-22.55%-29.95% 8.14B
+2.06%+6.90%-3.83%-26.10% 6.95B
+0.07%-3.72%+20.85%+30.13% 6.11B
+0.29%+0.46%-1.02%+23.20% 5.39B
-0.96%+2.99%-4.44%-4.91% 3.8B
Average +0.36%+1.03%+8.74%+45.34% 20.86B
Weighted average by Cap. -0.60%-1.17%+15.32%+108.58%

Financials

2026 *2027 *
Net sales 4.11B 1.01B 880M 812M 746M 1.41B 96.88B 1.44B 9.69B 3.8B 47.35B 3.78B 3.7B 163B 4.26B 1.04B 914M 843M 775M 1.47B 101B 1.49B 10.06B 3.95B 49.14B 3.92B 3.84B 169B
Net income 91.23M 22.37M 19.56M 18.04M 16.58M 31.42M 2.15B 31.96M 215M 84.51M 1.05B 84.01M 82.16M 3.63B 113M 27.78M 24.29M 22.41M 20.6M 39.02M 2.67B 39.69M 267M 105M 1.31B 104M 102M 4.5B
Net Debt - -
Logo Pharmaniaga
Pharmaniaga Berhad is an investment holding company engaged in the provision of management services to its subsidiaries. The Company’s segments include Manufacturing, Logistics and distribution, and Indonesia. The Manufacturing segment is engaged in manufacturing of pharmaceutical products in Malaysia. The Logistics and distribution segment includes distribution, trading and wholesaling of pharmaceutical and medical products as well as supply and installation of medical and hospital equipment in Malaysia. The Indonesia segment is engaged in manufacturing and distribution of pharmaceutical and medical products in Indonesia. Its product portfolio comprises oral solid dosages, liquid, cream and small volume injectables. It also manufactures general pharmaceuticals, including penicillin, cephalosporin and over-the-counter products. Its research and development capabilities include drug formulation and analytical development, process scale-up, clinical research and product localization.
Employees
3,502
Date Price Change Volume
26-07-16 MYR 1.170 -1.68% 1,201,100
26-07-15 MYR 1.190 -0.83% 1,101,500
26-07-14 MYR 1.200 +0.84% 3,340,900
26-07-13 MYR 1.190 -3.25% 1,821,700
26-07-10 MYR 1.230 0.00% 1,687,700
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.190MYR
Average target price
3.450MYR
Spread / Average Target
+189.92%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 7081 Stock